Novel compounds such as compounds designated herein as Xanifolia-Y or -Y3, -Y1, -Y2, -Y8, -Y9 and -Y10 are disclosed. These compounds have anticancer activity. The compounds of the present invention are obtainable from plants in the sapindaceae family, such as Xanthoceras sorbifolia, or other natural sources or products. The compounds of the present invention may also be synthesized chemically. 123

 
Web www.patentalert.com

< CD7 as biomarker and therapeutic target for psoriasis

< Pentose derivatives as anti-hyperglycemic drugs

> Superior molecular vaccine based on self-replicating rna, suicidal dna or naked dna vector, that links antigen with polypeptide that promotes antigen presentation

> RNA interference mediated inhibtion of vitamin D receptor gene expression using short interfering nucleic acid (siNA)

~ 00227